Nabil Seidah博士因发现PCSK9而获得2025年大阿拉伯医学思想奖,PCSK9是关键的胆固醇调控酶,导致获得救命药物。 Dr. Nabil Seidah won the 2025 Great Arab Minds Award in Medicine for discovering PCSK9, a key cholesterol-regulating enzyme that led to life-saving drugs.

埃及出生的科学家、蒙特利尔临床研究所生物化学神经内分泌学研究组主任Nabil Seidah博士赢得了2025年大阿拉伯医学精神奖,因为他开创性地发现了PCSK9酶。 PCSK9酶控制胆固醇水平,并导致开发了广泛使用的PCSK9抑制药物,以减少心脏病发作和中风风险。 Egyptian-born scientist Dr. Nabil Seidah, director of the Biochemical Neuroendocrinology Research Unit at Montreal's Clinical Research Institute, has won the 2025 Great Arab Minds Award in Medicine for his groundbreaking discovery of the PCSK9 enzyme, which regulates cholesterol levels and led to the development of widely used PCSK9 inhibitor drugs that reduce heart attack and stroke risk. 他的研究还增进了对脂肪肝病、肥胖症、癌症和病毒感染的认识。 His research has also advanced understanding of fatty liver disease, obesity, cancer, and viral infections. 由于有820多份出版物和71 000多份引文, " Seidah " 组织的工作产生了重大的全球性影响。 With over 820 publications and more than 71,000 citations, Seidah’s work has had a major global impact. 该奖项由Sheikh Mohammed bin Rashid Al Maktoum颁发,表彰阿拉伯在科学方面的杰出才华,并旨在激励后代的创新者。 The award, launched by Sheikh Mohammed bin Rashid Al Maktoum, recognizes exceptional Arab talent in science and aims to inspire future generations of innovators.